Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · Financials · Financial Conglomerates

LendingTree Inc

TREE · NASDAQ · USD · Market cap $510M · 919 employees

LendingTree, Inc., through its subsidiary, operates online consumer platform in the United States.

FAIL · Does not pass the screen
26.81 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price26.81 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.15)
  • Last reviewed23 Oct 2026 (5 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
48.3448.3448.34

What this means: price 26.81 against the desk's fair-value range, base estimate 48.34, over the last year.

Current read
Accumulation ?
Screened · screened 2026-10-23
  • Trend Accumulation
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.15, read 2026-10-24
  • Ethical does not pass the values gate
Price26.81 USD
Fair value48.34
Ethical score30.0/100
Our investment reviews on this name
2026-10-27Read Accumulation24.17+10.9% to today ✓Markdown gives way to Accumulation after a 34% slide in 6 weeks
2026-09-15Read Markdown36.55-26.6% to today ✓Distribution gives way to Markdown first Markdown read since July
2026-08-15Read Distribution36.55-26.6% to today ✓Markdown gives way to Distribution while volume still accumulates
2026-07-02Read Markdown36.55-26.6% to today ✓First review on file: Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its accumulation label.

LendingTree Inc holds its Accumulation at $26.81. Consolidating, no directional conviction, held for 48 days.

As held on the ledger · 2026-10-23
PhaseAccumulation
Quantitative stateConsolidating, no directional conviction, held for 48 days
Price at the screen$26.81
Valuation1.98 trailing · 3.78 forward price to earnings
Values screenFAIL · score 30.0
Beta2.05
The Workings

Five Screens, Shown in Full

Does not pass. Financial sector: Financial

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: Financial Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

LendingTree does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when TREE's ethical verdict changes

Today TREE does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

48.34Conservative48.34Base case48.34Growth case 26.81Price

Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.

The Street's Range
52.00Street low 67.50Street average 78.00Street high 26.81Price

Third-party analyst targets: 6 covering, consensus None. The average target sits +152% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections
$228$117$6TODAY5y agoPROJECTIONStreet high$78.00 +114%Street avg$67.50 +85%Conservative$48.34 +33%Our fair value$48.34 +33%

Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E3.8xcheap for a company growing this fast
Trailing P/E2.0xvery cheap relative to earnings
EPS, trailing12.92
EPS, forward6.78
Revenue growth+36.5%strong top-line growth
Profit margin15.0%healthy profit margins
Return on equity88.6%an exceptional return on shareholder capital
Debt to equity1.44a meaningful debt load worth watching
Beta2.05much more volatile than the market
52-week range32.65 - 77.35
MoatNONE
Market cap$510M
Employees919

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

TREE trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-28 Accumulation $24.17 +0.0% Entry 10

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Accumulation · changed $24.17 +0.0% Entry 9

The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markdown $24.17 +0.0% Entry 8

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-10-18 Markdown $24.17 -5.6% Entry 7

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-10-02 Markdown $25.61 -29.9% Entry 6

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 29.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-09-15 Markdown · changed $36.55 +0.0% Entry 5

The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-08-15 Distribution · changed $36.55 +0.0% Entry 4

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-07-18 Markdown $36.55 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (6 analysts) rates it strong buy, with a mean price target of $66.

2026-07-03 Markdown $36.55 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $36.55 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Political Ledger · Congressional Disclosures
Disclosures naming TREE
DatePoliticianPartyTypeAmount
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-09-25 Ro Khanna Democrat sell 1K–15K
2026-08-19 Gil Cisneros Democrat sell 15K–50K
2026-08-19 Gil Cisneros Democrat sell 15K–50K
2026-08-19 Gil Cisneros Democrat sell 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $37.16 -2.0% · $980 -2.0%
2 months $41.38 -12.0% · $880 -12.0%
3 months $39.76 -8.4% · $916 -8.4%
6 months $55.94 -34.9% · $651 -34.9%
1 year $36.30 +0.3% · $1,003 +0.3%
2 years $41.73 -12.7% · $873 -12.7%
3 years $21.55 +69.0% · $1,690 +69.0%
5 years $212.40 -82.9% · $172 -82.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever TREE does next, these words stay.

LendingTree Inc · TREE · Accumulation · $26.81
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.